Join us as members of the IASLC Education Committee moderate the program and lead discussions, including a Q&A session, following a panel presentation with Stella Martínez, MD, Lucia Viola, MD, and Andrés Cardona, MD. The event will cover key topics and provide a summary of the insightful presentations from the 2024 IASLC Latin America Conference on Lung Cancer (LALCA).
Learning Objectives:
- Examine scientific advances in thoracic cancer that can be used to make evidence-based diagnosis and treatment decisions.
- Synthesize cutting edge research from clinical trials and translational studies conducted around the world to deepen knowledge within primary specialty area(s) and broaden knowledge of other specialties.
- Apply evidence-based recommendations and clinical practice guidelines to diagnose and manage patients.
- Employ multidisciplinary teams to improve patient outcomes through patient-centered diagnostic, therapeutic and palliative care.
- Support and empower patients to become active participants in their treatment.
This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME). The International Association for the Study of Lung Cancer is accredited by the ACCME to provide continuing medical education for physicians.
The International Association for the Study of Lung Cancer designates the live format for this educational activity for a maximum of 1.00 AMA PRA Category 1 Credits™. Physicians should only claim credit commensurate with the extent of their participation in the activity.
Learning Objectives:
- Examine scientific advances in thoracic cancer that can be used to make evidence-based diagnosis and treatment decisions.
- Synthesize cutting edge research from clinical trials and translational studies conducted around the world to deepen knowledge within primary specialty area(s) and broaden knowledge of other specialties.
- Apply evidence-based recommendations and clinical practice guidelines to diagnose and manage patients.
- Employ multidisciplinary teams to improve patient outcomes through patient-centered diagnostic, therapeutic and palliative care.
- Support and empower patients to become active participants in their treatment.
This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME). The International Association for the Study of Lung Cancer is accredited by the ACCME to provide continuing medical education for physicians.
The International Association for the Study of Lung Cancer designates the live format for this educational activity for a maximum of 1.00 AMA PRA Category 1 Credits™. Physicians should only claim credit commensurate with the extent of their participation in the activity.